92 related articles for article (PubMed ID: 32879955)
21. Commentary on microRNA Fingerprint in Human Epithelial Ovarian Cancer.
Iorio MV; Croce CM
Cancer Res; 2016 Nov; 76(21):6143-6145. PubMed ID: 27803102
[No Abstract] [Full Text] [Related]
22. MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4.
Lin J; Zhang L; Huang H; Huang Y; Huang L; Wang J; Huang S; He L; Zhou Y; Jia W; Yun J; Luo R; Zheng M
Oncotarget; 2015 Sep; 6(27):23793-806. PubMed ID: 26204489
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways.
Majem B; Parrilla A; Jiménez C; Suárez-Cabrera L; Barber M; Marín A; Castellví J; Tamayo G; Moreno-Bueno G; Ponce J; Matias-Guiu X; Alameda F; Romero I; Sánchez JL; Pérez-Benavente A; Moran S; Esteller M; Reventós J; Rigau M; Gil-Moreno A; Segura MF; Santamaría A
Oncogene; 2019 Aug; 38(32):6035-6050. PubMed ID: 31278368
[TBL] [Abstract][Full Text] [Related]
24. Methylation-mediated repression of MiR-424/503 cluster promotes proliferation and migration of ovarian cancer cells through targeting the hub gene KIF23.
Li T; Li Y; Gan Y; Tian R; Wu Q; Shu G; Yin G
Cell Cycle; 2019 Jul; 18(14):1601-1618. PubMed ID: 31135262
[TBL] [Abstract][Full Text] [Related]
25. The role of long non-coding RNA PCA3 in epithelial ovarian carcinoma tumorigenesis and progression.
Liu Y; Zong ZH; Guan X; Wang LL; Zhao Y
Gene; 2017 Oct; 633():42-47. PubMed ID: 28864116
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway.
Zhuang XH; Liu Y; Li JL
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688
[TBL] [Abstract][Full Text] [Related]
27. MYC-regulated pseudogene HMGA1P6 promotes ovarian cancer malignancy via augmenting the oncogenic HMGA1/2.
Tian X; Song J; Zhang X; Yan M; Wang S; Wang Y; Xu L; Zhao L; Wei JJ; Shao C; Kong B; Liu Z
Cell Death Dis; 2020 Mar; 11(3):167. PubMed ID: 32127525
[TBL] [Abstract][Full Text] [Related]
28. Importance of promoter methylation of GATA4 gene in epithelial ovarian cancer.
Chmelarova M; Dvorakova E; Spacek J; Laco J; Palicka V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):294-7. PubMed ID: 24145767
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
Cancer Lett; 2015 Jun; 362(1):122-30. PubMed ID: 25819031
[TBL] [Abstract][Full Text] [Related]
30. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
[TBL] [Abstract][Full Text] [Related]
31. Lesser-Known Molecules in Ovarian Carcinogenesis.
Lozneanu L; Cojocaru E; Giuşcă SE; Cărăuleanu A; Căruntu ID
Biomed Res Int; 2015; 2015():321740. PubMed ID: 26339605
[TBL] [Abstract][Full Text] [Related]
32. Activation-Induced Cytidine Deaminase Links Ovulation-Induced Inflammation and Serous Carcinogenesis.
Sapoznik S; Bahar-Shany K; Brand H; Pinto Y; Gabay O; Glick-Saar E; Dor C; Zadok O; Barshack I; Zundelevich A; Gal-Yam EN; Yung Y; Hourvitz A; Korach J; Beiner M; Jacob J; Levanon EY; Barak M; Aviel-Ronen S; Levanon K
Neoplasia; 2016 Feb; 18(2):90-9. PubMed ID: 26936395
[TBL] [Abstract][Full Text] [Related]
33. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
34. Silencing the receptor of activated C-kinase 1 (RACK1) suppresses tumorigenicity in epithelial ovarian cancer in vitro and in vivo.
Lin Y; Cui M; Teng H; Wang F; Yu W; Xu T
Int J Oncol; 2014 Apr; 44(4):1252-8. PubMed ID: 24481459
[TBL] [Abstract][Full Text] [Related]
35. The mucin-type glycosylating enzyme polypeptide N-acetylgalactosaminyltransferase 14 promotes the migration of ovarian cancer by modifying mucin 13.
Wang R; Yu C; Zhao D; Wu M; Yang Z
Oncol Rep; 2013 Aug; 30(2):667-76. PubMed ID: 23708057
[TBL] [Abstract][Full Text] [Related]
36. Ectopic repression of receptor tyrosine kinase-like orphan receptor 2 inhibits malignant transformation of ovarian cancer cells by reversing epithelial-mesenchymal transition.
Xu Y; Ma YH; Pang YX; Zhao Z; Lu JJ; Mao HL; Liu PS
Tumour Biol; 2017 May; 39(5):1010428317701627. PubMed ID: 28475014
[TBL] [Abstract][Full Text] [Related]
37. Oncogenic and drug-sensitive RET mutations in human epithelial ovarian cancer.
Guan L; Li Z; Xie F; Pang Y; Zhang C; Tang H; Zhang H; Chen C; Zhan Y; Zhao T; Jiang H; Jia X; Wang Y; Lu Y
J Exp Clin Cancer Res; 2020 Mar; 39(1):53. PubMed ID: 32293499
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
39. Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?
Mitchell R; Buckingham L; Cobleigh M; Rotmensch J; Burgess K; Usha L
PLoS One; 2018; 13(4):e0195497. PubMed ID: 29659587
[TBL] [Abstract][Full Text] [Related]
40. EZH2-induced H3K27me3 is associated with epigenetic repression of the ARHI tumor-suppressor gene in ovarian cancer.
Fu Y; Chen J; Pang B; Li C; Zhao J; Shen K
Cell Biochem Biophys; 2015 Jan; 71(1):105-12. PubMed ID: 25077680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
